Skip to main content

Market Overview

Today's Morning Top Gainers (DDSS, UCBH, VG, CHIP, SYKE)

Share:

Labopharm Inc. (CAN) (NASDAQ: DDSS) is the top percentage gainers in morning trade and surged 29% today to $1.75 on huge volume of 3.61million shares after it announces that its trazodone api supplier has resolved outstanding manufacturing issues with the FDA.

UCBH Holdings, Inc. (NASDAQ: UCBH) after yesterday’s massive rally of about 75%, today again UCBH is up 21% on 21.69 million shares and now trades at $1.40. China Minsheng Banking Corp. is considering a plan to increase its stake in UCBH Holdings Inc., according to reports from Bloomberg.

Vonage Holdings Corp. (NYSE: VG) is also moving sharply by 21.53% to $1.75 on 23.08 million shares after After AT&T Inc. (NYSE: T) Allows VoIP Applications on iPhone. This morning Citigroup raised its price target to $1.50 from $0.50 despite maintaining a HOLD rating.

VeriChip Corporation (NASDAQ: CHIP) soared 23% now trades at $2.65 on an unusual volume of 3.61 million shares after announced today that VeriChip has received an exclusive license to RECEPTORS' Patent No. 7,504,364 titled "Methods of Making Arrays and Artificial Receptors" and Patent No. 7,469,076 "Sensors Employing Combinatorial Artificial Receptors," to use in conjunction with VeriChip's Patent No. 7,125,382 entitled "Embedded Bio-Sensor System," to develop an in vivo glucose-sensing RFID microchip.

Sykes Enterprises, Incorporated (NASDAQ: SYKE) climbed 9.20% to $24.81 on over 723K shares after Brigantine Advisors reiterates a 'Buy' rating on Sykes Enterprises , raises price target to $30 from $26.

 

Related Articles (CHIP + DDSS)

View Comments and Join the Discussion!

Posted-In: Intraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com